Medicalgorithmics S.A. — Regulatory Filings 2026

Apr 28, 2026

Report Content Subject: Medicalgorithmics S.A. receives an additional order from itsCanadian partner for Kardiobeat.ai devices worth USD 500,000.00 (approx.PLN 1.806.500,00 PLN)

Current report no.: 15/2026

Date of preparation: 27 April 2026

Legal basis: Article 17(1) of the MAR Regulation - confidentialinformation.

In reference to current report No. 39/2025 dated December 1, 2025,regarding the conclusion of an agreement (the "Agreement") betweenMedicalgorithmics S.A. with its registered office in Warsaw (the"Company", "Issuer") and a new partner from Canada - a provider ofdiagnostic and laboratory services - a publicly listed subsidiary of aglobal American diagnostics company (the "Partner"), the ManagementBoard of Medicalgorithmics S.A. announces that on April 28, 2026, itaccepted for execution an additional order from the Partner for thesupply of Kardiobeat.ai devices. This order is to be fulfilled in 2026and covers an increased quantity of devices sold by the Company comparedto the minimum order specified in the Agreement.

As a result of the execution of the additional order, the Company'santicipated remuneration from the Partner will increase relative to thecontractually guaranteed minimum revenues during the term of theAgreement, as previously reported by the Company in current report No.39/2025. The total value of the order received from the Partner amountsto USD 500,000.00, i.e. approximately PLN 1,806,500.00 according to theaverage exchange rate of the National Bank of Poland (NBP) as of April27, 2026. In accordance with the provisions of the Agreement, the orderwill be fulfilled following a 100% prepayment by the Partner. Inconnection with the Partner's additional order, the Issuer assumes thatthe minimum remuneration from the Partner during the term of theAgreement will amount to PLN 23,123,200.00 according to the average NBPexchange rate as of April 27, 2026.

The Agreement is in force from the date of its conclusion (December 1,2025) until March 31, 2028. After this period, the Agreement will beconverted into an agreement for an indefinite term and may be terminatedby either party with a 12-month notice period. In addition, theAgreement provides for the possibility of immediate termination in theevent of a material breach by one of the parties, following a priorunsuccessful demand to remedy the breach, as well as in the event of aforce majeure event lasting longer than the period specified in theAgreement, but only if the Company is unable to provide any services andfails to provide the Partner with a workable solution for the provisionof services under the Agreement within the specified timeframe.

In the opinion of the Management Board, receiving an additional orderexceeding the contracted minimum order is an important step in theimplementation of the Company's strategy presented in current report No.16/2023 dated June 19, 2023, which is aimed at significantly increasingthe Company's revenues and profitability and generating positive cashflows. In the opinion of the Company's Management Board, the additionalorder will contribute to strengthening the Company's presence in theNorth American market.